Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 199

1.

The influence of preferred place of birth on the course of pregnancy and labor among healthy nulliparous women: a prospective cohort study.

van Haaren-Ten Haken TM, Hendrix M, Smits LJ, Nieuwenhuijze MJ, Severens JL, de Vries RG, Nijhuis JG.

BMC Pregnancy Childbirth. 2015 Feb 14;15(1):33.

PMID:
25884308
2.

Economic evaluation of implementation strategies in health care.

Hoomans T, Severens JL.

Implement Sci. 2014 Dec 18;9(1):168. [Epub ahead of print]

3.

Real world cost of human epidermal receptor 2-positive metastatic breast cancer patients: a longitudinal incidence-based observational costing study in the Netherlands and Belgium.

Frederix GW, Severens JL, Hövels AM, van Hasselt JG, Hooiveld MJ, Neven P, Raaijmakers JA, Schellens JH.

Eur J Cancer Care (Engl). 2015 May;24(3):340-54. doi: 10.1111/ecc.12266. Epub 2014 Nov 21.

PMID:
25413216
4.

Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients.

Vaidya A, Joore MA, ten Cate-Hoek AJ, ten Cate H, Severens JL.

Biomark Med. 2014;8(8):989-99. doi: 10.2217/bmm.14.45.

PMID:
25343671
5.

Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes.

Handels RL, Wolfs CA, Aalten P, Bossuyt PM, Joore MA, Leentjens AF, Severens JL, Verhey FR.

BMC Neurol. 2014 Oct 4;14(1):190. [Epub ahead of print]

6.

Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?

Burgers LT, Nauta ST, Deckers JW, Severens JL, Redekop WK.

Int J Cardiol. 2014 Oct 20;176(3):980-7. doi: 10.1016/j.ijcard.2014.08.134. Epub 2014 Sep 2.

PMID:
25217221
7.

Consumer willingness to invest money and time for benefits of lifestyle behaviour change: an application of the contingent valuation method.

Alayli-Goebbels AF, van Exel J, Ament AJ, de Vries NK, Bot SD, Severens JL.

Health Expect. 2014 Aug 18. doi: 10.1111/hex.12195. [Epub ahead of print]

PMID:
25135005
8.

The effect of presenting information about invasive follow-up testing on individuals' noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment.

Benning TM, Dellaert BG, Severens JL, Dirksen CD.

Value Health. 2014 Jul;17(5):578-87. doi: 10.1016/j.jval.2014.04.007. Epub 2014 Jun 30.

PMID:
25128051
9.

A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Hiligsmann M, Cooper C, Guillemin F, Hochberg MC, Tugwell P, Arden N, Berenbaum F, Boers M, Boonen A, Branco JC, Maria-Luisa B, Bruyère O, Gasparik A, Kanis JA, Kvien TK, Martel-Pelletier J, Pelletier JP, Pinedo-Villanueva R, Pinto D, Reiter-Niesert S, Rizzoli R, Rovati LC, Severens JL, Silverman S, Reginster JY.

Semin Arthritis Rheum. 2014 Dec;44(3):271-82. doi: 10.1016/j.semarthrit.2014.06.005. Epub 2014 Jun 27.

10.

Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis.

Tran-Duy A, Boonen A, Kievit W, van Riel PL, van de Laar MA, Severens JL.

Pharmacoeconomics. 2014 Oct;32(10):1015-28. doi: 10.1007/s40273-014-0184-4.

PMID:
24972589
11.

High-sensitive troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation.

Vaidya A, Severens JL, Bongaerts BW, Cleutjens KB, Nelemans PJ, Hofstra L, van Dieijen-Visser M, Biessen EA.

BMC Cardiovasc Disord. 2014 Jun 13;14:77. doi: 10.1186/1471-2261-14-77.

12.

Challenges in modelling the cost effectiveness of various interventions for cardiovascular disease.

Burgers LT, Redekop WK, Severens JL.

Pharmacoeconomics. 2014 Jul;32(7):627-37. doi: 10.1007/s40273-014-0155-9. Review.

PMID:
24748448
13.

How to select the right cost-effectiveness model? : A systematic review and stepwise approach for selecting a transferable health economic evaluation model for rheumatoid arthritis.

van Haalen HG, Severens JL, Tran-Duy A, Boonen A.

Pharmacoeconomics. 2014 May;32(5):429-42. doi: 10.1007/s40273-014-0139-9. Review.

PMID:
24504853
14.

Cost-effectiveness of telehealth interventions for chronic heart failure patients: a literature review.

Grustam AS, Severens JL, van Nijnatten J, Koymans R, Vrijhoef HJ.

Int J Technol Assess Health Care. 2014 Jan;30(1):59-68. doi: 10.1017/S0266462313000779. Epub 2014 Feb 4.

PMID:
24495581
15.

Screen or not to screen for peripheral arterial disease: guidance from a decision model.

Vaidya A, Joore MA, Ten Cate-Hoek AJ, Ten Cate H, Severens JL.

BMC Public Health. 2014 Jan 29;14:89. doi: 10.1186/1471-2458-14-89.

16.

Preferences for potential innovations in non-invasive colorectal cancer screening: A labeled discrete choice experiment for a Dutch screening campaign.

Benning TM, Dellaert BG, Dirksen CD, Severens JL.

Acta Oncol. 2014 Jul;53(7):898-908. doi: 10.3109/0284186X.2013.877159. Epub 2014 Jan 23.

PMID:
24456499
17.

The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension.

van Gestel A, Schouten JS, Beckers HJ, Severens JL, Hendrikse F, Webers CA.

Acta Ophthalmol. 2014 Sep;92(6):513-23. doi: 10.1111/aos.12328. Epub 2013 Dec 16.

PMID:
24330516
18.

The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease-specific model standardization and improved guidance.

Frederix GW, van Hasselt JG, Schellens JH, Hövels AM, Raaijmakers JA, Huitema AD, Severens JL.

Pharmacoeconomics. 2014 Jan;32(1):47-61. doi: 10.1007/s40273-013-0106-x.

PMID:
24263964
19.

A systematic review of model-based economic evaluations of diagnostic and therapeutic strategies for lower extremity artery disease.

Vaidya A, Joore MA, ten Cate-Hoek AJ, Kleinegris MC, ten Cate H, Severens JL.

Thromb Haemost. 2014 Jan;111(1):19-28. doi: 10.1160/TH13-06-0498. Epub 2013 Oct 10. Review.

PMID:
24108319
20.

Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model.

Ramos GF, van Asselt AD, Kuiper S, Severens JL, Maas T, Dompeling E, Knottnerus JA, van Schayck OC.

Eur J Health Econ. 2014 Nov;15(8):869-83. doi: 10.1007/s10198-013-0532-x. Epub 2013 Oct 6.

PMID:
24096902
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk